settlement

By Mike Spector and Dietrich Knauth (Reuters) -Johnson & Johnson plans to pay an additional $1.1 billion to resolve tens of thousands of legal actions alleging its baby powder and other talc products caused cancer, two people familiar with the matter said. The increase would boost the size of the…

Johnson & Johnson (NYSE:) has made significant progress toward advancing its $6.5 billion plan to settle thousands of lawsuits from individuals who claim its baby powder caused cancer, Bloomberg News reported on Monday. More than 75% of those involved approved J&J’s proposal in a confidential vote that concluded in late…

By Dietrich Knauth NEW YORK (Reuters) -Johnson & Johnson has cleared a key threshold of support for its proposed $6.5 billion settlement of tens of thousands of lawsuits alleging its baby powder and other talc products caused cancer, according to a Bloomberg report. More than 75% of claimants voted in…

By Laura Matthews and Carolina Mandl NEW YORK (Reuters) – U.S. trading on Tuesday moved to a shorter settlement cycle for securities transactions, putting investors and regulators on alert for increased trade failures and other hiccups in the world’s largest financial market over the coming days. Investors in U.S. equities,…